Kassberg Thomas Richard

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 13% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Kassberg Thomas Richard's trades of Ultragenyx Pharmaceutical Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-04 2025-03-03
S Sale
39,204 +49.8%
89.23
US$2,713,798 		39,204 +49.8% 89.23 US$2,713,798
2024-03-12 2024-03-11
S Sale
89,002 -23.6%
365.66
US$3,992,361 		89,002 -23.6% 365.66 US$3,992,361
2024-03-11 2024-03-11
PrS Proposed sale
3,213
301.69
US$2,909,344 		3,213 301.69 US$2,909,344
2024-03-05 2024-03-01
S Sale
1,011 -0.4%
53.76
US$54,351 		1,011 -0.4% 53.76 US$54,351
2023-10-24 2023-10-23
S Sale
39,878 -13.9%
32.78
US$1,307,201 		39,878 -13.9% 32.78 US$1,307,201
2023-10-23 2023-10-23
PrS Proposed sale
39,878
32.78
US$1,307,077 		39,878 32.78 US$1,307,077
2023-03-03 2023-03-01
S Sale
1,968 -0.8%
45.27
US$89,091 		1,968 -0.8% 45.27 US$89,091
2022-03-15 2022-03-11
S Sale
10,281 -4.3%
67.01
US$688,930 		10,281 -4.3% 67.01 US$688,930
2022-03-03 2022-03-01
S Sale
2,374 -1.1%
66.62
US$158,156 		2,374 -1.1% 66.62 US$158,156
2021-10-18 2021-10-14
S Sale
286 -0.1%
81.14
US$23,206 		286 -0.1% 81.14 US$23,206
2021-03-03 2021-03-01
PlS Planned sale
4,572 -4.1%
138.17
US$631,713 		4,572 -4.1% 138.17 US$631,713
2020-10-16 2020-10-14
S Sale
262 -0.3%
87.98
US$23,051 		262 -0.3% 87.98 US$23,051